ICAM-2 Antibody (3C4) is a rat monoclonal IgG2a antibody that detects ICAM-2 in mouse samples through immunofluorescence (IF) and flow cytometry (FCM) applications. ICAM-2, also known as CD102, is a crucial member of the intercellular adhesion molecule family, primarily expressed on endothelial cells and leukocytes, where anti-ICAM-2 antibody (3C4) plays a significant role in mediating cell adhesion and migration during immune responses. ICAM-2 serves as a ligand for lymphocyte function-associated antigen-1 (LFA-1), facilitating the adhesion of leukocytes to endothelial cells, which is essential for the recruitment of immune cells to sites of inflammation. The interaction between ICAM-2 and LFA-1 not only promotes leukocyte adhesion but also influences the activation and proliferation of T cells, thereby contributing to the overall immune response. ICAM-2 is involved in maintaining the integrity of the blood-brain barrier, highlighting ICAM-2′s importance in both immune regulation and central nervous system function. With specific reactivity and versatile applications, ICAM-2 (3C4) antibody serves as an invaluable tool for researchers studying cell adhesion mechanisms and immune responses in mouse models.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
ICAM-2 Antibody (3C4) References:
- Overlapping and selective roles of endothelial intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 in lymphocyte trafficking. | Lehmann, JC., et al. 2003. J Immunol. 171: 2588-93. PMID: 12928410
- ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. | Tanaka, H., et al. 2004. Clin Cancer Res. 10: 4885-92. PMID: 15269165
- Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. | Huang, MT., et al. 2005. Blood. 106: 1636-43. PMID: 15920013
- Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. | Steiner, O., et al. 2010. J Immunol. 185: 4846-55. PMID: 20861356
- β2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. | Gorina, R., et al. 2014. J Immunol. 192: 324-37. PMID: 24259506
- ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling. | Amsellem, V., et al. 2014. Cell Commun Signal. 12: 12. PMID: 24593809
- Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis. | Haghayegh Jahromi, N., et al. 2019. Front Immunol. 10: 3056. PMID: 31993059
- ICAM-2 redistributed by ezrin as a target for killer cells. | Helander, TS., et al. 1996. Nature. 382: 265-8. PMID: 8717043
- Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to alpha-actinin. | Heiska, L., et al. 1996. J Biol Chem. 271: 26214-9. PMID: 8824270
- ICAM-2 provides a costimulatory signal for T cell stimulation by allogeneic class II MHC. | Carpenito, C., et al. 1997. Scand J Immunol. 45: 248-54. PMID: 9122613